ArticleLeukemia2003

Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones.

Y L Chee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.